Published in Transplantation on November 15, 2008
The diploid genome sequence of an individual human. PLoS Biol (2007) 44.80
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet (2009) 14.01
Gestational hypertension and preeclampsia in living kidney donors. N Engl J Med (2014) 7.25
Genome sequence of the dissimilatory metal ion-reducing bacterium Shewanella oneidensis. Nat Biotechnol (2002) 6.96
Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc Natl Acad Sci U S A (2002) 5.28
HIV treatment response and prognosis in Europe and North America in the first decade of highly active antiretroviral therapy: a collaborative analysis. Lancet (2006) 5.00
Phase III study of immediate compared with delayed docetaxel after front-line therapy with gemcitabine plus carboplatin in advanced non-small-cell lung cancer. J Clin Oncol (2008) 4.79
Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies. AIDS (2007) 4.31
The genome sequence of the anaerobic, sulfate-reducing bacterium Desulfovibrio vulgaris Hildenborough. Nat Biotechnol (2004) 3.43
Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care (2012) 3.20
Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation. Transplantation (2013) 2.55
Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries. Int J Epidemiol (2009) 2.51
Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis. Lancet Oncol (2013) 2.48
Access to kidney transplantation among remote- and rural-dwelling patients with kidney failure in the United States. JAMA (2009) 2.26
Microfluidic device for multimodal characterization of pancreatic islets. Lab Chip (2008) 1.99
The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy. Arch Intern Med (2005) 1.97
Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal. Clin Infect Dis (2009) 1.86
A novel equation to estimate glomerular filtration rate using beta-trace protein. Clin Chem (2007) 1.85
Cardiovascular disease and hypertension risk in living kidney donors: an analysis of health administrative data in Ontario, Canada. Transplantation (2008) 1.83
Impact of non-compliance on outcome after pediatric kidney transplantation: an analysis in racial subgroups. Pediatr Transplant (2004) 1.82
Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial. J Clin Oncol (2008) 1.79
Totally robotic right hepatectomy: surgical technique and outcomes. Arch Surg (2011) 1.75
Retention among North American HIV-infected persons in clinical care, 2000-2008. J Acquir Immune Defic Syndr (2013) 1.73
Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis. J Acquir Immune Defic Syndr (2013) 1.72
The effect of race and income on living kidney donation in the United States. J Am Soc Nephrol (2013) 1.72
Factors associated with discordance between absolute CD4 cell count and CD4 cell percentage in patients coinfected with HIV and hepatitis C virus. Clin Infect Dis (2012) 1.71
Robotic versus open pancreaticoduodenectomy: a comparative study at a single institution. World J Surg (2011) 1.70
The hepatitis C epidemic among HIV-positive MSM: incidence estimates from 1990 to 2007. AIDS (2011) 1.65
Human adrenal glands secrete vitamin C in response to adrenocorticotrophic hormone. Am J Clin Nutr (2007) 1.60
Acute dialysis risk in living kidney donors. Nephrol Dial Transplant (2012) 1.60
Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data. Am J Kidney Dis (2006) 1.59
The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodology. Epidemiology (2011) 1.59
Post-transplant focal segmental glomerulosclerosis refractory to plasmapheresis and rituximab therapy. Nephrol Dial Transplant (2007) 1.58
Role of echocardiography in detecting portopulmonary hypertension in liver transplant candidates. Liver Transpl (2002) 1.56
CXCL10 impairs beta cell function and viability in diabetes through TLR4 signaling. Cell Metab (2009) 1.55
Potential impact of in situ liver splitting on the number of available grafts. Transplantation (2002) 1.55
Robotic liver surgery: results for 70 resections. Surgery (2010) 1.55
Survival among patients with kidney failure in Jalisco, Mexico. J Am Soc Nephrol (2007) 1.53
Calcineurin inhibitor withdrawal from sirolimus-based therapy in kidney transplantation: a systematic review of randomized trials. Am J Transplant (2005) 1.53
Predictors of weight gain and cardiovascular risk in a cohort of racially diverse kidney transplant recipients. Nutrition (2002) 1.51
Living kidney donor follow-up: state-of-the-art and future directions, conference summary and recommendations. Am J Transplant (2011) 1.51
Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America. AIDS (2015) 1.44
Hilar early division of the hepatic duct in living donor right hepatectomy: the probe-and-clamp technique. Liver Transpl (2006) 1.44
Staged approach for abdominal wound closure following combined liver and intestinal transplantation from living donors in pediatric patients. Pediatr Transplant (2008) 1.43
Successful simultaneous pancreas kidney transplantation from living-related donor against positive cross-match. Am J Transplant (2004) 1.41
Estimating glomerular filtration rate in kidney transplantation: is the new chronic kidney disease epidemiology collaboration equation any better? Clin Chem (2009) 1.39
The impact of transmitted drug resistance on the natural history of HIV infection and response to first-line therapy. AIDS (2006) 1.37
Estimating glomerular filtration rate in kidney transplantation: a comparison between serum creatinine and cystatin C-based methods. J Am Soc Nephrol (2005) 1.36
Spliced leader-based metatranscriptomic analyses lead to recognition of hidden genomic features in dinoflagellates. Proc Natl Acad Sci U S A (2010) 1.35
Long-term mortality in HIV-positive individuals virally suppressed for >3 years with incomplete CD4 recovery. Clin Infect Dis (2014) 1.25
Improved human pancreatic islet purification with the refined UIC-UB density gradient. Transplantation (2007) 1.22
Trace elements in hemodialysis patients: a systematic review and meta-analysis. BMC Med (2009) 1.21
Performance of creatinine-based estimates of GFR in kidney transplant recipients: a systematic review. Am J Kidney Dis (2008) 1.20
Cohort profile: the Canadian HIV-hepatitis C co-infection cohort study. Int J Epidemiol (2009) 1.17
Estimating GFR using serum beta trace protein: accuracy and validation in kidney transplant and pediatric populations. Kidney Int (2009) 1.14
Major families of multiresistant plasmids from geographically and epidemiologically diverse staphylococci. G3 (Bethesda) (2011) 1.14
Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms: data from seroconverters in the CASCADE collaboration from 1987 to 2003. J Acquir Immune Defic Syndr (2005) 1.14
Microfluidic perifusion and imaging device for multi-parametric islet function assessment. Biomed Microdevices (2010) 1.13
Functional MR microimaging of pancreatic beta-cell activation. Cell Transplant (2006) 1.12
De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects. Transplantation (2007) 1.11
The effect of antiretroviral treatment of different durations in primary HIV infection. AIDS (2008) 1.11
Robotically assisted donor nephrectomy for kidney transplantation. Am J Surg (2004) 1.10
Prevention of contrast-induced acute kidney injury: is simple oral hydration similar to intravenous? A systematic review of the evidence. PLoS One (2013) 1.09
Combined living-related segmental liver and bowel transplantation for megacystis-microcolon-intestinal hypoperistalsis syndrome. J Pediatr Surg (2008) 1.08
Anastomosing hemangioma arising from the adrenal gland. Urology (2012) 1.07
Similar outcomes among black and white renal allograft recipients. J Am Soc Nephrol (2008) 1.07
Five-year follow-up of patients with type 1 diabetes transplanted with allogeneic islets: the UIC experience. Acta Diabetol (2014) 1.05
Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression. J Acquir Immune Defic Syndr (2009) 1.04
Human islet isolation outcomes from pancreata preserved with Histidine-Tryptophan Ketoglutarate versus University of Wisconsin solution. Transplantation (2006) 1.04
Robot-assisted right lobe donor hepatectomy. Transpl Int (2011) 1.03
Conversion from calcineurin inhibitors to sirolimus for chronic renal allograft dysfunction: a systematic review of the evidence. Transplantation (2006) 1.02
Treatment of polyomavirus infection in kidney transplant recipients: a systematic review. Transplantation (2010) 1.02
A descriptive analysis of 1251 solid organ transplant visits to the emergency department. West J Emerg Med (2009) 1.00
Living related small bowel transplantation in children: 3-dimensional computed tomography donor evaluation. Pediatr Transplant (2004) 1.00
The feasibility of using an 'opt-out' approach to achieve universal HIV testing of tuberculosis patients in Alberta. Can J Public Health (2009) 0.99
Functional capacity of human islets after long-distance shipment and encapsulation. Pancreas (2011) 0.99
Reduction of blood glucose variability in type 1 diabetic patients treated by pancreatic islet transplantation: interest of continuous glucose monitoring. Diabetes Care (2002) 0.99
Mortality in HIV-hepatitis C co-infected patients in Canada compared to the general Canadian population (2003-2013). AIDS (2014) 0.98
Bone and mineral metabolism and fibroblast growth factor 23 levels after kidney donation. Am J Kidney Dis (2011) 0.97
Encapsulation of human islets in novel inhomogeneous alginate-ca2+/ba2+ microbeads: in vitro and in vivo function. Artif Cells Blood Substit Immobil Biotechnol (2008) 0.97
Islet preconditioning via multimodal microfluidic modulation of intermittent hypoxia. Anal Chem (2012) 0.97
Chronic kidney disease management: comparison between renal transplant recipients and nontransplant patients with chronic kidney disease. Nephron Clin Pract (2007) 0.97
Effect of prolonged gelling time on the intrinsic properties of barium alginate microcapsules and its biocompatibility. J Microencapsul (2011) 0.97
Effect of clinical variables and immunosuppression on serum cystatin C and beta-trace protein in kidney transplant recipients. Am J Kidney Dis (2009) 0.96
Do biochemical measures change in living kidney donors? A systematic review. Nephron Clin Pract (2007) 0.96
Barriers to blood pressure control and angiotensin enzyme inhibitor use in Canadian patients with chronic renal insufficiency. Nephrol Dial Transplant (2002) 0.96
Infectious complications associated with the use of rituximab for ABO-incompatible and positive cross-match renal transplant recipients. Clin Transplant (2007) 0.95